Substance use disorder and other predictors of antidepressant-induced mania: A retrospective chart review

Journal of Clinical Psychiatry

Volumn 67, Issue 9, 2006, Pages 1341-1345

  Manwani, Sumita G ^a,b   Pardo, Tamara B ^a,b   Albanese, Mark J ^a,b   Zablotsky, Benjamin ^a,b   Goodwin, Frederick K ^c   Ghaemi, S Nassir ^d,e  

^a CAMBRIDGE HEALTH ALLIANCE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; CANNABIS; COCAINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OPIATE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER; VALPROATE SEMISODIUM; VALPROIC ACID;

BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICAL RECORD; MOOD DISORDER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBSTANCE ABUSE; SUBSTANCE USE DISORDER;

EID: 33750062566     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0903     Document Type: Review

References (26)

1. Goodwin F, Jamison K. Manic Depressive Illness. New York, NY: Oxford University Press; 1990
2. Ghaemi SN, Rosenquist K, Ko J, et al. Effects of newer and older antidepressants in bipolar depression [abstract]. Bipolar Disord 2003;5(suppl 1):49
3. Ghaemi SN, Sachs GS, Baldassano CF. Treatment-resistant bipolar disorder: clinical aspects and management. In: Pollack M, Rosenbaum JF, eds. Challenges in Psychiatric Treatment: Pharmacologic and Psychosocial Strategies. New York, NY: Guilford Press; 1996:53-88
4. Goldberg JF, Rabin A, Whiteside JE. Prevalence and risks associated with antidepressant-induced mania. In: New Research Program and Abstracts of the 154th Annual Meeting of the American Psychiatric Association; May 9, 2001; New Orleans, La. Abstract NR539
5. Henry C, Sorbara F, Lacoste J, et al. Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 2001;62:249-255
6. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164:549-550
7. Truman C, Baldassano C, Goldberg J. History of antidepressant-induced mania in the STEP 500. In: New Research Program and Abstracts of the 156th Annual Meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif. Abstract NR29
8. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537-1547
9. Mendlewicz J, Youdim MB. Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness. J Affect Disord 1980;2:137-146
10. Himmelhoch J, Fuchs C, Symons B. A double-blind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis 1982;170:628-634
11. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-1088
12. Cohn JB, Collins G, Ashbrook E, et al. A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989;4:313-314
13. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-912
14. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials. New York, NY: Springer-Verlag; 1998
15. Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003;5:407-420
16. Rothman K, Greenland S. Modern Epidemiology. Philadelphia, Pa: Lippincott-Raven; 1998
17. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990;264:2511-2518
18. Albanese MJ, Clodfelter RC Jr, Pardo TB, et al. Underdiagnosis of bipolar disorder in men with substance use disorder. J Psychiatr Pract 2006;12:124-127
19. Kessler RC, Crum RM, Warner LA, et al. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313-321
20. Albanese MJ, Pies R. The bipolar patient with comorbid substance use disorder: recognition and management. CNS Drugs 2004;18:585-596
21. Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001;52:469-476
22. Goldberg J, Whiteside J. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2002;63:791-795
23. Sachs GS. Strategies for improving treatment of bipolar disorder: integration of measurement and management. Acta Psychiatr Scand Suppl 2004;422:7-17
24. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV. New York, NY: Biometric Research, New York State Psychiatric Institute; 1995
25. Rothman KJ. Epidemiology: An Introduction. Oxford, England: Oxford University Press; 2002
26. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication updated October 2004. Mymensingh Med J 2005;14:95-119